1,3-dioxolane derivatives as cholesterol-lowering agents

Compounds of formula (I): wherein n is 2 or 3; p is 0, 1 or 2; q is 0, 1 or 2; X is oxygen or S(O)t where t is 0, 1 or 2; each R is independently halo, lower alkyl, lower alkoxy, or trifluoromethyl; each R is independently halo or lower alkyl; R is nitro or -N(R )R where R is hydrogen or lower alkyl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PAMELA M. BURTON, KEITH A. M. WALKER, DAVID C. SWINNEY
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PAMELA M. BURTON
KEITH A. M. WALKER
DAVID C. SWINNEY
description Compounds of formula (I): wherein n is 2 or 3; p is 0, 1 or 2; q is 0, 1 or 2; X is oxygen or S(O)t where t is 0, 1 or 2; each R is independently halo, lower alkyl, lower alkoxy, or trifluoromethyl; each R is independently halo or lower alkyl; R is nitro or -N(R )R where R is hydrogen or lower alkyl; R is hydrogen, lower alkyl, lower alkylsulfonyl or -C(Y)R where Y is oxygen or sulfur and R is hydrogen, lower alkyl, lower alkoxy or -N(R )R where R is hydrogen or lower alkyl and R is hydrogen, lower alkyl or lower alkoxycarbonyl; or R and R together with N is pyrrolidino, piperidino, morpholino, thiomorpholino or piperazino, wherein the piperazino is optionally substituted at the 4-position by -C(O)R where R is hydrogen, lower alkyl, lower alkoxy or amino; and R is hydrogen or lower alkyl, as single stereoisomers or as mixtures thereof; and their pharmaceutically acceptable salts, are useful in treating disease-states characterized by hypercholesterolemia.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU650079BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU650079BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU650079BB23</originalsourceid><addsrcrecordid>eNrjZLAw1DHWTcnMr8jPScxLVUhJLcosSyzJLEstVkgsVkjOyM9JLS5JLcrP0c3JLwdK5qUrJKan5pUU8zCwpiXmFKfyQmluBgU31xBnD93Ugvz41OKCxOTUvNSSeMdQM1MDA3NLJycjYyKUAACk4y4b</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>1,3-dioxolane derivatives as cholesterol-lowering agents</title><source>esp@cenet</source><creator>PAMELA M. BURTON ; KEITH A. M. WALKER ; DAVID C. SWINNEY</creator><creatorcontrib>PAMELA M. BURTON ; KEITH A. M. WALKER ; DAVID C. SWINNEY</creatorcontrib><description>Compounds of formula (I): wherein n is 2 or 3; p is 0, 1 or 2; q is 0, 1 or 2; X is oxygen or S(O)t where t is 0, 1 or 2; each R is independently halo, lower alkyl, lower alkoxy, or trifluoromethyl; each R is independently halo or lower alkyl; R is nitro or -N(R )R where R is hydrogen or lower alkyl; R is hydrogen, lower alkyl, lower alkylsulfonyl or -C(Y)R where Y is oxygen or sulfur and R is hydrogen, lower alkyl, lower alkoxy or -N(R )R where R is hydrogen or lower alkyl and R is hydrogen, lower alkyl or lower alkoxycarbonyl; or R and R together with N is pyrrolidino, piperidino, morpholino, thiomorpholino or piperazino, wherein the piperazino is optionally substituted at the 4-position by -C(O)R where R is hydrogen, lower alkyl, lower alkoxy or amino; and R is hydrogen or lower alkyl, as single stereoisomers or as mixtures thereof; and their pharmaceutically acceptable salts, are useful in treating disease-states characterized by hypercholesterolemia.</description><edition>5</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1994</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19940609&amp;DB=EPODOC&amp;CC=AU&amp;NR=650079B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19940609&amp;DB=EPODOC&amp;CC=AU&amp;NR=650079B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PAMELA M. BURTON</creatorcontrib><creatorcontrib>KEITH A. M. WALKER</creatorcontrib><creatorcontrib>DAVID C. SWINNEY</creatorcontrib><title>1,3-dioxolane derivatives as cholesterol-lowering agents</title><description>Compounds of formula (I): wherein n is 2 or 3; p is 0, 1 or 2; q is 0, 1 or 2; X is oxygen or S(O)t where t is 0, 1 or 2; each R is independently halo, lower alkyl, lower alkoxy, or trifluoromethyl; each R is independently halo or lower alkyl; R is nitro or -N(R )R where R is hydrogen or lower alkyl; R is hydrogen, lower alkyl, lower alkylsulfonyl or -C(Y)R where Y is oxygen or sulfur and R is hydrogen, lower alkyl, lower alkoxy or -N(R )R where R is hydrogen or lower alkyl and R is hydrogen, lower alkyl or lower alkoxycarbonyl; or R and R together with N is pyrrolidino, piperidino, morpholino, thiomorpholino or piperazino, wherein the piperazino is optionally substituted at the 4-position by -C(O)R where R is hydrogen, lower alkyl, lower alkoxy or amino; and R is hydrogen or lower alkyl, as single stereoisomers or as mixtures thereof; and their pharmaceutically acceptable salts, are useful in treating disease-states characterized by hypercholesterolemia.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1994</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAw1DHWTcnMr8jPScxLVUhJLcosSyzJLEstVkgsVkjOyM9JLS5JLcrP0c3JLwdK5qUrJKan5pUU8zCwpiXmFKfyQmluBgU31xBnD93Ugvz41OKCxOTUvNSSeMdQM1MDA3NLJycjYyKUAACk4y4b</recordid><startdate>19940609</startdate><enddate>19940609</enddate><creator>PAMELA M. BURTON</creator><creator>KEITH A. M. WALKER</creator><creator>DAVID C. SWINNEY</creator><scope>EVB</scope></search><sort><creationdate>19940609</creationdate><title>1,3-dioxolane derivatives as cholesterol-lowering agents</title><author>PAMELA M. BURTON ; KEITH A. M. WALKER ; DAVID C. SWINNEY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU650079BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1994</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PAMELA M. BURTON</creatorcontrib><creatorcontrib>KEITH A. M. WALKER</creatorcontrib><creatorcontrib>DAVID C. SWINNEY</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PAMELA M. BURTON</au><au>KEITH A. M. WALKER</au><au>DAVID C. SWINNEY</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>1,3-dioxolane derivatives as cholesterol-lowering agents</title><date>1994-06-09</date><risdate>1994</risdate><abstract>Compounds of formula (I): wherein n is 2 or 3; p is 0, 1 or 2; q is 0, 1 or 2; X is oxygen or S(O)t where t is 0, 1 or 2; each R is independently halo, lower alkyl, lower alkoxy, or trifluoromethyl; each R is independently halo or lower alkyl; R is nitro or -N(R )R where R is hydrogen or lower alkyl; R is hydrogen, lower alkyl, lower alkylsulfonyl or -C(Y)R where Y is oxygen or sulfur and R is hydrogen, lower alkyl, lower alkoxy or -N(R )R where R is hydrogen or lower alkyl and R is hydrogen, lower alkyl or lower alkoxycarbonyl; or R and R together with N is pyrrolidino, piperidino, morpholino, thiomorpholino or piperazino, wherein the piperazino is optionally substituted at the 4-position by -C(O)R where R is hydrogen, lower alkyl, lower alkoxy or amino; and R is hydrogen or lower alkyl, as single stereoisomers or as mixtures thereof; and their pharmaceutically acceptable salts, are useful in treating disease-states characterized by hypercholesterolemia.</abstract><edition>5</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU650079BB2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title 1,3-dioxolane derivatives as cholesterol-lowering agents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T03%3A15%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PAMELA%20M.%20BURTON&rft.date=1994-06-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU650079BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true